XCF Global Signs Commercial Collaboration Agreement with Axens North America
XCF Global announced the execution of a commercial collaboration agreement with Axens North America. This collaboration is anticipated to enable XCF to deploy its proprietary modular refinery design and engineering blueprint in combination with Axens Vegan process through a licensing-based model intended to accelerate the development of domestic and global SAF capacity. Under the agreement, it is expected that XCF and Axens will collaborate to engage with potential project developers and plant owners interested in deploying sustainable fuels facilities. Axens will continue to license its proprietary Vegan process directly to customers, while XCF may independently offer its project management, construction, and operational services based on its experience developing and operating services through a licensing approach, leveraging its experience building and operating a commercial Vegan unit in the United States. The Commercial Collaboration Agreement has an initial term of three years.
Trade with 70% Backtested Accuracy
Analyst Views on SAFX
About SAFX
About the author
XCF Global Assesses Notice and Financial Implications, Engages in Talks with Phillips 66 - SEC Filing
- Financial Evaluation: Discussions are ongoing regarding the financial impact of evaluating notices.
- Involvement of Phillips: The evaluation process includes consultations with Phillips, indicating a collaborative approach.
XCF Global Inc: Phillips 66 to End Supply and Offtake Agreement with New Rise Renewables Reno Starting May 1, 2026 - SEC Filing
Supply Termination: Global Inc. has announced the termination of its supply agreement with New Riser Renewables, effective May 1, 2026.
Offtake Agreement: The termination also includes an offtake agreement, indicating a significant shift in their business relationship.
XCF GLOBAL INC - SEC FILING REVEALS INITIAL THREE-YEAR TERM FROM PRODUCTION START IN TERM SHEET
- Global Interterm Sheet: The Global Interterm Sheet has initiated a three-year term from the start of production.
- SEC Filing: The relevant details have been filed with the SEC.
XCF GLOBAL INC - SIGNS TERM SHEET FOR RENEWABLE FUEL TOLLING AGREEMENT WITH BGN DATED APRIL 9, 2026 - SEC FILING
Global Renewable Fuel Tolling Agreement: Global Inc. has entered into a renewable fuel tolling agreement with BGN, effective April 9, 2026.
SEC Filing: The details of this agreement have been filed with the SEC, indicating compliance with regulatory requirements.
XCF Global, Inc. Reports FY Earnings
- Earnings Highlights: XCF Global, Inc. reported a FY GAAP EPS of $0.52, indicating stable profitability amidst market challenges, which may reassure investors about the company's financial health.
- Revenue Performance: The company achieved revenue of $20.82 million, showing growth compared to the previous year, reflecting its competitive position in the market and sustained customer demand, which enhances confidence in future growth.
- Quant Rating Insight: Seeking Alpha's Quant Rating on XCF Global, Inc. provides an in-depth analysis of the company's financial health, aiding investors in understanding its market positioning and potential investment value.
- Historical Data Context: The historical earnings data for XCF Global, Inc. offers crucial context for analyzing its long-term performance, allowing investors to assess growth trends and future prospects.
The Oncology Institute Reports Strong Q4 Results, Shares Surge
- Earnings Beat: The Oncology Institute reported a Q4 loss of 6 cents per share, outperforming the analyst consensus estimate of a 9-cent loss, indicating improvements in cost management and operational efficiency, which boosts market confidence in its future profitability.
- Sales Growth: The company achieved quarterly sales of $141.957 million, exceeding the analyst consensus of $139.775 million, reflecting positive progress in market demand and product promotion, thereby strengthening its market position in oncology treatment.
- Stock Surge: Shares of The Oncology Institute jumped 14.7% to $3.01 in pre-market trading, demonstrating a positive investor reaction to the financial results, which may attract more investor interest in its future developments.
- Increased Market Confidence: The better-than-expected performance not only enhances investor confidence but may also prompt analysts to reassess the company's long-term growth potential, potentially influencing future stock price movements and market performance.
XCF Global Assesses Notice and Financial Implications, Engages in Talks with Phillips 66 - SEC Filing
- Financial Evaluation: Discussions are ongoing regarding the financial impact of evaluating notices.
- Involvement of Phillips: The evaluation process includes consultations with Phillips, indicating a collaborative approach.
XCF Global Inc: Phillips 66 to End Supply and Offtake Agreement with New Rise Renewables Reno Starting May 1, 2026 - SEC Filing
Supply Termination: Global Inc. has announced the termination of its supply agreement with New Riser Renewables, effective May 1, 2026.
Offtake Agreement: The termination also includes an offtake agreement, indicating a significant shift in their business relationship.
XCF GLOBAL INC - SEC FILING REVEALS INITIAL THREE-YEAR TERM FROM PRODUCTION START IN TERM SHEET
- Global Interterm Sheet: The Global Interterm Sheet has initiated a three-year term from the start of production.
- SEC Filing: The relevant details have been filed with the SEC.
XCF GLOBAL INC - SIGNS TERM SHEET FOR RENEWABLE FUEL TOLLING AGREEMENT WITH BGN DATED APRIL 9, 2026 - SEC FILING
Global Renewable Fuel Tolling Agreement: Global Inc. has entered into a renewable fuel tolling agreement with BGN, effective April 9, 2026.
SEC Filing: The details of this agreement have been filed with the SEC, indicating compliance with regulatory requirements.
XCF Global, Inc. Reports FY Earnings
- Earnings Highlights: XCF Global, Inc. reported a FY GAAP EPS of $0.52, indicating stable profitability amidst market challenges, which may reassure investors about the company's financial health.
- Revenue Performance: The company achieved revenue of $20.82 million, showing growth compared to the previous year, reflecting its competitive position in the market and sustained customer demand, which enhances confidence in future growth.
- Quant Rating Insight: Seeking Alpha's Quant Rating on XCF Global, Inc. provides an in-depth analysis of the company's financial health, aiding investors in understanding its market positioning and potential investment value.
- Historical Data Context: The historical earnings data for XCF Global, Inc. offers crucial context for analyzing its long-term performance, allowing investors to assess growth trends and future prospects.
The Oncology Institute Reports Strong Q4 Results, Shares Surge
- Earnings Beat: The Oncology Institute reported a Q4 loss of 6 cents per share, outperforming the analyst consensus estimate of a 9-cent loss, indicating improvements in cost management and operational efficiency, which boosts market confidence in its future profitability.
- Sales Growth: The company achieved quarterly sales of $141.957 million, exceeding the analyst consensus of $139.775 million, reflecting positive progress in market demand and product promotion, thereby strengthening its market position in oncology treatment.
- Stock Surge: Shares of The Oncology Institute jumped 14.7% to $3.01 in pre-market trading, demonstrating a positive investor reaction to the financial results, which may attract more investor interest in its future developments.
- Increased Market Confidence: The better-than-expected performance not only enhances investor confidence but may also prompt analysts to reassess the company's long-term growth potential, potentially influencing future stock price movements and market performance.
